PortfoliosLab logo
HIMS vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HIMS and LLY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HIMS vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HIMS:

2.78

LLY:

-0.11

Sortino Ratio

HIMS:

2.94

LLY:

0.08

Omega Ratio

HIMS:

1.39

LLY:

1.01

Calmar Ratio

HIMS:

5.08

LLY:

-0.20

Martin Ratio

HIMS:

10.77

LLY:

-0.40

Ulcer Index

HIMS:

29.79%

LLY:

12.45%

Daily Std Dev

HIMS:

110.09%

LLY:

38.01%

Max Drawdown

HIMS:

-87.29%

LLY:

-68.27%

Current Drawdown

HIMS:

-24.41%

LLY:

-23.23%

Fundamentals

Market Cap

HIMS:

$9.13B

LLY:

$737.66B

EPS

HIMS:

$0.53

LLY:

$12.27

PE Ratio

HIMS:

79.02

LLY:

66.95

PEG Ratio

HIMS:

3.85

LLY:

1.33

PS Ratio

HIMS:

6.18

LLY:

15.05

PB Ratio

HIMS:

19.15

LLY:

46.91

Total Revenue (TTM)

HIMS:

$1.78B

LLY:

$49.00B

Gross Profit (TTM)

HIMS:

$1.33B

LLY:

$40.03B

EBITDA (TTM)

HIMS:

$123.98M

LLY:

$16.67B

Returns By Period

In the year-to-date period, HIMS achieves a 114.89% return, which is significantly higher than LLY's -4.68% return.


HIMS

YTD

114.89%

1M

76.20%

6M

121.96%

1Y

302.17%

5Y*

39.21%

10Y*

N/A

LLY

YTD

-4.68%

1M

-2.54%

6M

-11.36%

1Y

-4.17%

5Y*

38.56%

10Y*

28.50%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HIMS vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS
The Risk-Adjusted Performance Rank of HIMS is 9696
Overall Rank
The Sharpe Ratio Rank of HIMS is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of HIMS is 9494
Sortino Ratio Rank
The Omega Ratio Rank of HIMS is 9393
Omega Ratio Rank
The Calmar Ratio Rank of HIMS is 9999
Calmar Ratio Rank
The Martin Ratio Rank of HIMS is 9595
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 4141
Overall Rank
The Sharpe Ratio Rank of LLY is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 3939
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 3939
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 3939
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 4444
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HIMS vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HIMS Sharpe Ratio is 2.78, which is higher than the LLY Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of HIMS and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HIMS vs. LLY - Dividend Comparison

HIMS has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.74%.


TTM20242023202220212020201920182017201620152014
HIMS
Hims & Hers Health, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.74%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

HIMS vs. LLY - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for HIMS and LLY. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HIMS vs. LLY - Volatility Comparison


Loading data...

Financials

HIMS vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
586.01M
12.73B
(HIMS) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

HIMS vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Hims & Hers Health, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

70.0%75.0%80.0%20212022202320242025
73.5%
82.5%
(HIMS) Gross Margin
(LLY) Gross Margin
HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Hims & Hers Health, Inc. reported a gross profit of 430.69M and revenue of 586.01M. Therefore, the gross margin over that period was 73.5%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Hims & Hers Health, Inc. reported an operating income of 57.90M and revenue of 586.01M, resulting in an operating margin of 9.9%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Hims & Hers Health, Inc. reported a net income of 49.49M and revenue of 586.01M, resulting in a net margin of 8.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.